Latest News for: lrk

Edit

Larkspur Biosciences Begins Dosing in Clinical Study of LRK-4189, a First-in-Class Targeted

Black Hills Pioneer 08 Dec 2025
LRK-4189, which targets PIP4K2C, a key cancer cell ...
Edit

Larkspur Biosciences Begins Dosing in Clinical Study of LRK-4189, a First-in-Class Targeted Protein Degrader

Nasdaq Globe Newswire 03 Dec 2025
Larkspur Biosciences announced the first participant has been dosed in the Phase 1 clinical study of its lead candidate, LRK-4189, in healthy volunteers ... .
  • 1

Article Search

tools
×
×
×
×